Cyclacel Pharmaceuticals News - CYCCP

Company Name	Stock Ticker Symbol	Market	Type
Cyclacel Pharmaceuticals Inc	CYCCP	NASDAQ	Preference Share

	Price Change	Change Percent	Stock Price	Last Traded
	-0.30	-3.75%	7.70	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
9.97	7.70	10.97	7.70	8.00

more quote information »

Recent News

Date	Time	Source	Heading
6/04/2024	08:00	GLOBE	Cyclacel’s Fadraciclib Demonstrates Efficacy in..
6/03/2024	08:00	GLOBE	Cyclacel Pharmaceuticals Reports New Clinical Data at 2024..
5/17/2024	09:56	EDGAR2	Form D - Notice of Exempt Offering of Securities
5/14/2024	17:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/2024	16:05	EDGAR2	Form 8-K - Current report
5/14/2024	16:05	GLOBE	Cyclacel Pharmaceuticals Reports First Quarter Financial..
5/13/2024	16:05	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
5/08/2024	09:15	GLOBE	Cyclacel Pharmaceuticals to Release First Quarter 2024..
5/07/2024	21:53	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
5/07/2024	21:52	EDGAR2	Form DEF 14A - Other definitive proxy statements
5/06/2024	17:26	EDGAR2	Form S-1 - General form for registration of securities under..
5/02/2024	16:30	GLOBE	Cyclacel Pharmaceuticals Announces Closing of $8.0 Million..
4/30/2024	13:51	APS	$8 Million Private Placement Announcement Sends Biotech..
4/30/2024	07:00	GLOBE	Cyclacel Pharmaceuticals Announces $8.0 Million Private..
4/01/2024	09:15	GLOBE	Cyclacel Pharmaceuticals to Present New Clinical Data at..
3/19/2024	16:05	GLOBE	Cyclacel Pharmaceuticals Reports Fourth Quarter and Full..
3/13/2024	16:05	GLOBE	Cyclacel Pharmaceuticals to Release Fourth Quarter and Full..
3/07/2024	09:15	GLOBE	Cyclacel Pharmaceuticals Announces Preclinical..
3/06/2024	09:15	GLOBE	Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
2/20/2024	09:15	GLOBE	Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
2/14/2024	16:31	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/14/2024	10:09	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	15:47	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/07/2024	17:03	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/31/2024	16:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/30/2024	09:15	EDGAR2	Form 8-K - Current report
1/30/2024	09:15	GLOBE	Cyclacel Pharmaceuticals Announces the Appointment of Brian..
1/19/2024	16:58	EDGAR2	Form S-1 - General form for registration of securities under..
1/12/2024	16:05	EDGAR2	Form 8-K - Current report
1/10/2024	13:35	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/04/2024	16:30	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/04/2024	16:05	EDGAR2	Form 8-K - Current report
12/26/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	09:29	EDGAR2	Form 8-K - Current report
12/26/2023	09:28	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
12/18/2023	09:00	GLOBE	Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data..
12/12/2023	16:06	EDGAR2	Form 8-K - Current report
12/12/2023	16:05	GLOBE	Cyclacel Pharmaceuticals Announces Reverse Stock Split
11/30/2023	09:15	GLOBE	Cyclacel Regains Compliance With Nasdaq Listing Rule..
11/28/2023	21:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/28/2023	21:20	EDGAR2	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/28/2023	17:15	GLOBE	Cyclacel Receives Notification of Deficiency From Nasdaq..
11/28/2023	16:59	EDGAR2	Form 8-K - Current report
11/15/2023	17:04	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
11/15/2023	17:03	EDGAR2	Form 8-K - Current report
11/13/2023	16:06	EDGAR2	Form 8-K - Current report
11/07/2023	16:10	EDGAR2	Form 8-K - Current report
11/07/2023	09:15	GLOBE	Cyclacel Pharmaceuticals to Release Third Quarter 2023..